US Stock MarketDetailed Quotes
BLU BELLUS Health
- 14.740
- 0.0000.00%
Close Jun 29 09:30 ET
1.87BMarket Cap-20191P/E (TTM)
0.000High0.000Low0Volume0.000Open14.740Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)126.81MShares14.76052wk High5.07P/B1.39BFloat Cap14.73052wk Low--Dividend TTM94.60MShs Float14.760Historical High--Div YieldTTM0.00%Amplitude2.010Historical Low--Avg Price1Lot Size
BELLUS Health Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -80.90%-27.1M | -25.94%-77.1M | -42.50%-30.73M | -29.87%-18.05M | -37.69%-13.33M | 6.76%-14.98M | -105.80%-61.22M | -119.58%-21.57M | -199.07%-13.9M | -93.43%-9.68M |
| Net income from continuing operations | -74.61%-25.06M | -6.82%-76.08M | -23.58%-18.25M | -7.98%-24.71M | -5.32%-18.78M | 8.88%-14.35M | -124.28%-71.22M | -97.01%-14.76M | -300.79%-22.88M | -111.68%-17.83M |
| Depreciation and amortization | 44.44%104K | 58.03%305K | 56.14%89K | 60.00%72K | 56.52%72K | 60.00%72K | 7.82%193K | 26.67%57K | 0.00%45K | 4.55%46K |
| Other non cash items | -179.21%-2.69M | -10.16%-2.03M | -131.63%-3.49M | 3,192.31%1.71M | 449.26%709K | -422.83%-962K | -46.38%-1.84M | -120.03%-1.51M | 109.03%52K | 78.59%-203K |
| Change In working capital | -34.91%-2.39M | -283.18%-9.71M | -69.37%-11.58M | -74.47%1.9M | -73.60%1.74M | 6.64%-1.77M | 411.76%5.3M | -120.47%-6.84M | 4,560.63%7.46M | 119.91%6.58M |
| -Change in receivables | -37.59%-399K | -17.78%-371K | ---372K | 892.16%404K | -476.67%-113K | 1.36%-290K | -241.89%-315K | --0 | -109.92%-51K | 112.30%30K |
| -Change in prepaid assets | 376.25%3.91M | -106.46%-9.17M | -12.11%-4.55M | -22.24%-2.03M | -156.45%-1.17M | -77.10%-1.42M | -7,301.67%-4.44M | -67.40%-4.06M | -299.52%-1.66M | 127.10%2.08M |
| -Change in payables and accrued expense | -6,623.86%-5.92M | -102.07%-213K | -160.59%-6.68M | -61.24%3.56M | -33.00%3M | 89.08%-88K | 651.74%10.28M | -428.45%-2.56M | 872.05%9.17M | 92.68%4.48M |
| -Change in other working capital | -25.00%15K | 117.73%39K | --15K | ---21K | --25K | --20K | ---220K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -80.90%-27.1M | -25.94%-77.1M | -42.50%-30.73M | -29.87%-18.05M | -37.69%-13.33M | 6.76%-14.98M | -105.80%-61.22M | -119.58%-21.57M | -199.07%-13.9M | -93.43%-9.68M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 99.91%25.28M | -207.43%-148.27M | 169.51%45.02M | -2,012.50%-193.93M | -288.43%-12M | 57,372.73%12.64M | -314.34%-48.23M | -101.18%-64.76M | -72.19%10.14M | -24.54%6.37M |
| Net investment purchase and sale | 89.32%23.8M | -209.02%-149.87M | 168.23%44.25M | -2,034.60%-194.43M | -294.40%-12.26M | --12.57M | -323.69%-48.5M | -98.88%-64.86M | -71.95%10.05M | -25.50%6.31M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 99.91%25.28M | -207.43%-148.27M | 169.51%45.02M | -2,012.50%-193.93M | -288.43%-12M | 57,372.73%12.64M | -314.34%-48.23M | -101.18%-64.76M | -72.19%10.14M | -24.54%6.37M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 74.59%-219K | -22.27%163.11M | -100.23%-480K | 444,872.97%164.57M | 5.83%-113K | -82.63%-862K | 462.09%209.86M | 468.68%210.49M | -114.40%-37K | -142.11%-120K |
| Net issuance payments of debt | -117.31%-113K | -58.37%-331K | -30.14%-95K | -129.41%-78K | -55.88%-106K | -52.94%-52K | -11.76%-209K | -14.06%-73K | 27.66%-34K | -51.11%-68K |
| Net common stock issuance | ---- | -22.20%163.75M | -100.42%-889K | ---- | ---- | ---- | 464.30%210.47M | --210.47M | ---- | ---- |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | -75.90%20K | 126.79%127K | -17.86%46K | --0 | ---2K | --83K | -90.62%56K | --56K | --0 | --0 |
| Net other financing activities | 85.92%-125K | 8.82%-393K | 1,039.02%467K | --28K | --0 | -111.43%-888K | -23.14%-431K | 119.16%41K | --0 | 79.45%-52K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 74.59%-219K | -22.27%163.11M | -100.23%-480K | 444,872.97%164.57M | 5.83%-113K | -82.63%-862K | 462.09%209.86M | 468.68%210.49M | -114.40%-37K | -142.11%-120K |
| Net cash flow | ||||||||||
| Beginning cash position | -41.86%87.25M | 206.98%150.08M | 188.25%72.86M | 317.98%121.72M | 353.38%147.16M | 206.98%150.08M | 161.61%48.89M | -52.81%25.28M | 36.98%29.12M | 86.07%32.46M |
| Current changes in cash | 36.13%-2.04M | -162.00%-62.25M | -88.88%13.8M | -1,148.42%-47.42M | -641.10%-25.44M | 80.63%-3.2M | 233.70%100.41M | 2,584.73%124.16M | -111.84%-3.8M | -192.31%-3.43M |
| Effect of exchange rate changes | -38.99%169K | -174.10%-575K | -8.45%585K | -3,097.78%-1.44M | -97.92%2K | 222.09%277K | 605.45%776K | 98.45%639K | -119.31%-45K | -1.03%96K |
| End cash Position | -41.98%85.38M | -41.86%87.25M | -41.86%87.25M | 188.25%72.86M | 317.98%121.72M | 353.38%147.16M | 206.98%150.08M | 206.98%150.08M | -52.81%25.28M | 36.98%29.12M |
| Free cash flow | -80.90%-27.1M | -25.94%-77.1M | -42.50%-30.73M | -29.87%-18.05M | -37.69%-13.33M | 6.76%-14.98M | -102.16%-61.22M | -126.52%-21.57M | -180.89%-13.9M | -87.18%-9.68M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data